DSM extends focus on growth

Chemicals company DSM booked net profit of €507m in 2010, almost 50% up on 2009. Sales rose 22% to over €89bn.

The group’s Nutrition division performed particularly well but the pharmaceuticals arm needs improvement, the company said in a statement. DSM also increased its dividend by 8%.
‘The year 2010 was the last in a period of transformation for DSM to become a focused Life Sciences and Materials Sciences company,’ said CEO Feike Sijbesma.
‘We successfully completed our Vision 2010 strategy, including divesting the remaining non-core assets within the promised timescale… and have started to build additional strong growth platforms for the next phase of our strategy.’

Thank you for donating to DutchNews.nl.

We could not provide the Dutch News service, and keep it free of charge, without the generous support of our readers. Your donations allow us to report on issues you tell us matter, and provide you with a summary of the most important Dutch news each day.

Make a donation